NasdaqGS - Nasdaq Real Time Price • USD Clover Health Investments, Corp. (CLOV) Follow Compare 4.4300 -0.0200 (-0.45%) At close: January 30 at 4:00:02 PM EST 4.4397 +0.01 +(0.22%) After hours: 7:58:17 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations 3 US Growth Companies With High Insider Ownership That Insiders Favor As U.S. markets navigate a period of uncertainty with the Federal Reserve maintaining interest rates and investors closely watching major tech earnings, attention turns to identifying promising growth opportunities. In such a climate, companies with high insider ownership can be appealing, as they often signal confidence from those most familiar with the business's potential. US Penny Stocks To Watch In January 2025 As the U.S. stock market experiences a pause after a strong rally, investors are keenly observing shifts in major indexes and sectors, particularly with recent developments in technology and AI-related stocks. For those considering investments beyond the well-trodden paths of large-cap equities, penny stocks—though an older term—still represent intriguing opportunities within smaller or emerging companies. By focusing on those with solid financial health and potential for growth, these stocks... Why Clover Health Investments, Corp. (CLOV) Is Skyrocketing in 2025 We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look at where Clover Health Investments, Corp. (NASDAQ:CLOV) stands against the other stocks that are skyrocketing now. The market has started to favor smaller companies in 2025, and stocks between $1 billion […] Clover Health Sees 27% Growth in Medicare Members An update from Clover Health Investments ( (CLOV) ) is now available. Clover Health announced a significant 27% growth in its Medicare Advantage membership following a successful Annual Election Period, reaching over 100,000 members, with 95% enrolled in its 4-Star PPO plan. This growth, driven by robust plan benefits and a high Star rating, positions the company for continued success and profitability in 2025, supported by strategic investments in technology and care management improvements. Th Clover Health Reports 27% Growth in Medicare Advantage Membership, Surpassing 100,000 Lives After Strong Annual Election Period Robust plan benefits powered member growth, mainly driven by switchers from other plansCompany will focus on balancing profitability with strategic investments in growth and technology to take advantage of strong market opportunity~95% of Clover’s January 1, 2025 membership is in its flagship 4 Star PPO plan WILMINGTON, Del., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced a 27% year-over-year growth Clover Health Investments Corp. (CLOV): This Small-Cap Stock Is Poised To Outperform in 2025 We recently compiled a list of the 15 Small-Cap Stocks Poised to Outperform in 2025. In this article, we are going to take a look at where Clover Health Investments Corp. (NASDAQ:CLOV) stands against the other small-cap stocks. Fifteen small-cap stocks—predominantly under the technology sector—are taking center stage this year, boasting triple- to quadruple-digit performance in […] Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care Organization WILLMINGTON, Del., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced it has successfully deployed its Counterpart Assistant technology within Duke Connected Care (DCC), a recognized leader in accountable care and part of the prestigious Duke University Health System. Counterpart is a subsidiary of Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover Health”). Based in Durham, North Carolina, DCC is a physi US Growth Companies With High Insider Ownership As the U.S. stock market wraps up a strong year with some recent turbulence, major indices like the Nasdaq Composite and S&P 500 have still managed to post impressive gains, highlighting a period of robust growth despite recent setbacks. In this environment, identifying growth companies with high insider ownership can be particularly appealing to investors seeking alignment between management and shareholder interests, as these firms often demonstrate confidence in their long-term potential... December 2024's Promising US Penny Stocks As December 2024 unfolds, the U.S. stock market presents a mixed landscape, with the Dow Jones Industrial Average marking its fifth consecutive day of gains while the S&P 500 and Nasdaq Composite see minor declines. In this context, investors often turn to penny stocks—smaller or newer companies that can offer significant opportunities despite their somewhat outdated name. By focusing on those with strong financial foundations and potential for growth, investors can uncover hidden value in... Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Remote-First Company -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 4:30 p.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible from Clover Health's investor relations website at https://in Cerus And 2 Other US Penny Stocks To Watch The U.S. stock market recently experienced a stumble, particularly in technology shares, as investors assessed earnings reports and economic data amidst fluctuating interest rates and inflation expectations. In such a climate, the appeal of penny stocks remains significant for those seeking affordable entry points with potential growth prospects. While the term "penny stocks" may seem outdated, these typically smaller or newer companies can offer unique opportunities when supported by strong... Clover Health Investments Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag Clover Health Investments ( NASDAQ:CLOV ) Third Quarter 2024 Results Key Financial Results Revenue: US$331.0m (down 31... Clover Health Investments Corp (CLOV) Q3 2024 Earnings Call Highlights: Strong Financial ... Clover Health Investments Corp (CLOV) reports improved profitability and reaffirms full-year guidance amid strategic investments and technology-driven advancements. Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership Delivers 9% Total Revenue growth year-to-date compared to prior year period Company improves 2024 year-to-date GAAP Net Loss from Continuing Operations by $117.4 million year-over-year and year-to-date Adjusted EBITDA by $87.2 million year-over-year Increases Full-Year 2024 guidance midpoint to target updated range of Adjusted EBITDA profitability of $55 million - $65 million, strongly positioning the Company to invest in membership growth opportunity for 2025 FRANKLIN, Tenn., Nov. 06, 2024 (GLO Top US Penny Stocks To Watch In October 2024 As investors navigate a landscape marked by mixed economic signals and fluctuating stock indices, penny stocks continue to capture attention for their unique potential. Although the term 'penny stock' may sound outdated, it remains relevant in identifying smaller or newer companies that could offer substantial growth opportunities. By focusing on those with solid financial foundations, investors can uncover promising prospects within this intriguing segment of the market. Clover Health to Participate in Upcoming Investor Conferences FRANKLIN, Tenn., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences: CFO, Peter Kuipers, will present at the 2024 UBS Global Healthcare Conference on Tuesday, November 12, 2024, at 5:00 p.m. Eastern Time.CFO, Peter Kuipers, will participate in the Canaccord Genuity 2024 Medical Technology, Diagnostics, and Digital Health & Services Forum on Thursday Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation Just because a business does not make any money, does not mean that the stock will go down. For example, Clover Health... Clover Health to Report Third Quarter 2024 Financial Results on November 6 FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report third quarter 2024 financial results after market close on Wednesday, November 6, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on November 6, 2024, to discuss Clover Health’s third quarter 2024 business and financial results. Third Quarter 2024 Conference Call and Webcast Details: What: Clover Health’s Thir 2025 Clover Health Medicare Advantage Benefits Demonstrate Commitment to New Jersey Seniors Company’s affordable, benefit-rich flagship PPO plans now have 4 Star ratingFRANKLIN, Tenn., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV) (“Clover” or “the Company”) has announced the debut of its 2025 Medicare Advantage (MA) plan offerings in New Jersey. Clover offers a range of affordable and flexible healthcare options for Medicare beneficiaries, which are designed to meet the unique needs of New Jersey seniors, especially those on fixed incomes facing rising costs of living Clover Health PPO Medicare Advantage Plans Earn 4 Star Rating for 2025 Overall Star rating performance increase was driven by exceptional performance on healthcare quality measures, Medication Adherence and Member ExperienceFRANKLIN, Tenn., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that the Centers for Medicare and Medicaid Services (“CMS”) has increased the Star rating of its PPO Medicare Advantage (“MA”) plans to 4 Stars for 2025, which will affect payment year 2 Performance Overview Trailing total returns as of 1/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return CLOV S&P 500 YTD +38.87% +2.78% 1-Year +347.47% +23.20% 3-Year +91.77% +36.99%